Cara Delevingne was first introduced to L’Oreal Paris’ Women of Worth program a couple of years ago when she attended its annual gala for the first time. “It was one of the most inspiring, touching, ...
Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...
Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
Timothy Graham receives funding from the Australian Research Council (ARC) for the Discovery Project, 'Understanding and Combatting "Dark Political Communication"'. A new study published today in ...
MILFORD, Mass., Feb. 17, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today launched 1 mm I.D. liquid chromatography (LC) columns with Waters' MaxPeak™ Premier Technology for its ACQUITY™, ...
Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
This is my granddaughter Abigail writing which makes the 4th generation since my mother Elizabeth Coblentz started penning the column (then called “The Amish Cook”) in 1991. Hi, this is Abigail ...
Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...
Nick Shirley’s investigation of alleged million-dollar day care fraud in Minnesota showcases him visiting seemingly empty day cares in the early morning, peering into windows, and asking the same ...
While the creation of this new entity marks a big step toward avoiding a U.S. ban, as well as easing trade and tech-related tensions between Washington and Beijing, there is still uncertainty ...